Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (326)
ARTG (289)
Prescription medicine registration (29)
Designation or determination (2)
Prescription medicine evaluation (2)

Date

2026 (46)
2025 (31)
2024 (51)
2023 (161)
2022 (30)
2021 (55)
2020 (45)
2019 (26)
2018 (50)
2017 (35)
2016 (77)
2015 (2)
2014 (1)
2013 (9)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

648 result(s) found, displaying 391 to 400

TERIFLUNOMIDE-REDDY'S teriflunomide 14 mg tablet blister pack (304230)

8 April 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TERIFLUNOMIDE-REDDY'S teriflunomide 14 mg tablet blister pack.
TERIFLUNOMIDE-DRLA teriflunomide 14 mg tablet blister pack (304231)

8 April 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TERIFLUNOMIDE-DRLA teriflunomide 14 mg tablet blister pack.
BLOOMS THE CHEMIST FEXOFENADINE HAYFEVER & ALLERGY RELIEF fexofenadine hydrochloride 180 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
APOHEALTH FEXOFENADINE 180 HAYFEVER & ALLERGY RELIEF fexofenadine hydrochloride 180 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN GENERICHEALTH rosuvastatin (as calcium) 10 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
DASATINIB DR.REDDY'S, DASATINIB-DRLA, DASATINIB-RZ, REDDY'S-DASATINIB (Dr Reddys Laboratories Australia Pty Ltd)

12 May 2021

Prescription medicine registration

Active ingredients: dasatinib propylene glycol.
DAPTOMYCIN DR.REDDY'S, DAPTOMYCIN-DRLA, DAPTOMYCIN-RZ, REDDY'S-DAPTOMYCIN (Dr Reddys Laboratories Australia Pty Ltd)

9 April 2021

Prescription medicine registration

Active ingredients: daptomycin.
SEVELAMER-REDDY'S sevelamer carbonate 800 mg film-coated tablet bottle (286649)

9 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SEVELAMER-REDDY'S sevelamer carbonate 800 mg film-coated tablet bottle.
SEVELAMER-DRLA sevelamer carbonate 800 mg film-coated tablet bottle (286650)

9 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SEVELAMER-DRLA sevelamer carbonate 800 mg film-coated tablet bottle.
ARX-SEVELAMER sevelamer carbonate 800 mg film-coated tablet bottle (286648)

9 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ARX-SEVELAMER sevelamer carbonate 800 mg film-coated tablet bottle.

Pages

First page
Previous page
…
Page 36
Page 37
Page 38
Page 39
Current page 40
Page 41
Page 42
Page 43
Page 44
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.